chr11-94456284-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_005591.4(MRE11):c.1555G>T(p.Val519Phe) variant causes a missense change. The variant allele was found at a frequency of 0.00000248 in 1,610,280 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_005591.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MRE11 | NM_005591.4 | c.1555G>T | p.Val519Phe | missense_variant | Exon 14 of 20 | ENST00000323929.8 | NP_005582.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MRE11 | ENST00000323929.8 | c.1555G>T | p.Val519Phe | missense_variant | Exon 14 of 20 | 1 | NM_005591.4 | ENSP00000325863.4 | ||
MRE11 | ENST00000323977.7 | c.1555G>T | p.Val519Phe | missense_variant | Exon 14 of 19 | 1 | ENSP00000326094.3 | |||
MRE11 | ENST00000407439.7 | c.1564G>T | p.Val522Phe | missense_variant | Exon 14 of 20 | 2 | ENSP00000385614.3 | |||
MRE11 | ENST00000393241.8 | c.1555G>T | p.Val519Phe | missense_variant | Exon 14 of 20 | 5 | ENSP00000376933.4 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152072Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000798 AC: 2AN: 250750Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135562
GnomAD4 exome AF: 6.86e-7 AC: 1AN: 1458208Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 725582
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152072Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74262
ClinVar
Submissions by phenotype
Ataxia-telangiectasia-like disorder 1 Uncertain:1
- -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.V519F variant (also known as c.1555G>T), located in coding exon 13 of the MRE11A gene, results from a G to T substitution at nucleotide position 1555. The valine at codon 519 is replaced by phenylalanine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Ataxia-telangiectasia-like disorder Uncertain:1
This sequence change replaces valine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 519 of the MRE11 protein (p.Val519Phe). This variant is present in population databases (rs778116138, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with MRE11-related conditions. ClinVar contains an entry for this variant (Variation ID: 481755). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at